In this issue:
Benefits of a fasting-mimicking diet
Recommendations for exams under anaesthesia, seton insertion and removal
Impact of IUS transmural healing
Safety and tolerability of VE202
Applicator preferences for subcutaneous biologics
Application of STRIDE-II guidelines in newly diagnosed paediatric patients
Efficacy of advanced therapies based on disease location
Subcutaneous infliximab effectiveness based on disease location
Second-line therapies after first-line vedolizumab
Can structural and functional abnormalities predict loss of therapeutic targets
Please login below to download this issue (PDF)